Atlas Trials

A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients

Clinical trial NCT06082557 · UNKNOWN

Trial details

NCT number
NCT06082557
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Malignant Solid Tumors
Start date
2023-10-01
Primary completion
2025-03-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.